We are live on
!
Find out more
Artisan Partners Portfolio holdings
AUM
$61.3B
1-Year Est. Return
26.25%
This Fund
S&P 500
This Quarter
Est. Return
-2.12%
1 Year Est. Return
+26.25%
3 Year Est. Return
+105.27%
5 Year Est. Return
+134.81%
10 Year Est. Return
+672.1%
AUM
$61.3B
AUM Growth
-$4.07B
(-6.2%)
Cap. Flow
-$917M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
25.01%
Holding
365
New
37
Increased
119
Reduced
167
Closed
35
Top Buys
| 1 |
Coupang
CPNG
|
+$659M |
| 2 |
Axalta
AXTA
|
+$515M |
| 3 |
JPMorgan Chase
JPM
|
+$355M |
| 4 |
Edwards Lifesciences
EW
|
+$333M |
| 5 |
IQVIA
IQV
|
+$329M |
Top Sells
| 1 |
Suncor Energy
SU
|
+$860M |
| 2 |
Lam Research
LRCX
|
+$653M |
| 3 |
PayPal
PYPL
|
+$439M |
| 4 |
Netflix
NFLX
|
+$365M |
| 5 |
Danaher
DHR
|
+$317M |
Sector Composition
| 1 | Financials | 26.49% |
| 2 | Healthcare | 18.86% |
| 3 | Technology | 17.27% |
| 4 | Industrials | 10.97% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Cellebrite
CLBT
$4.04B
| $30.1M | 0.05% |
2,185,797
+750,909
| +52% | +$11.3M |
|
252
Public Storage
PSA
$56B
| $29.9M | 0.05% |
110,277
-7,953
| -7% | -$2.28M |
|
253
Procept Biorobotics
PRCT
$1.1B
| $29.7M | 0.05% |
1,187,349
-333,351
| -22% | -$9.39M |
|
254
Acadia Pharmaceuticals
ACAD
$4.36B
| $29.6M | 0.05% |
+1,331,813
| New | +$31.8M |
|
|
RAL
255
Ralliant Corp
RAL
$7.56B
| $28.9M | 0.05% |
694,284
-48,018
| -6% | -$2.26M |
|
256
Kaspi.kz JSC
KSPI
$16.9B
| $28.6M | 0.05% |
386,095
+33,101
| +9% | +$2.5M |
|
257
Raymond James Financial
RJF
$32.6B
| $28.3M | 0.05% |
+195,666
| New | +$31M |
|
258
Warby Parker
WRBY
$3.39B
| $28.3M | 0.05% |
1,342,003
+243,589
| +22% | +$6.04M |
|
259
Paychex
PAYX
$38.9B
| $27.6M | 0.05% |
+299,664
| New | +$29.6M |
|
260
Revvity
RVTY
$12.4B
| $27.4M | 0.04% |
312,370
-21,598
| -6% | -$2.14M |
|
|
BWIN
261
Baldwin Insurance Group
BWIN
$2.58B
| $26.7M | 0.04% |
+1,217,970
| New | +$26.3M |
|
262
Kodiak Sciences
KOD
$2.71B
| $26.3M | 0.04% |
690,322
-146,184
| -17% | -$3.78M |
|
263
Calix
CALX
$2.49B
| $26M | 0.04% |
529,875
-60,312
| -10% | -$3.17M |
|
264
Mercury Systems
MRCY
$6.02B
| $25.8M | 0.04% |
+354,265
| New | +$30.8M |
|
|
PVLA
265
Palvella Therapeutics
PVLA
$2.15B
| $24.2M | 0.04% |
193,796
-17,757
| -8% | -$1.85M |
|
|
CRCL
266
Circle Internet Group
CRCL
$15.7B
| $23.9M | 0.04% |
+250,076
| New | +$21.2M |
|
267
Palantir
PLTR
$321B
| $22.8M | 0.04% |
+156,084
| New | +$23.9M |
|
268
HealthEquity
HQY
$7.9B
| $22.6M | 0.04% |
270,942
-271,274
| -50% | -$22.3M |
|
|
SAIL
269
SailPoint Inc
SAIL
$8.62B
| $22.6M | 0.04% |
1,706,651
-33,473
| -2% | -$522K |
|
270
Repligen
RGEN
$8.3B
| $22.4M | 0.04% |
190,100
-3,597
| -2% | -$502K |
|
271
Tarsus Pharmaceuticals
TARS
$2.45B
| $21.6M | 0.04% |
307,307
-129,269
| -30% | -$9.03M |
|
|
KRMN
272
Karman Holdings
KRMN
$6.07B
| $21.4M | 0.03% |
+267,574
| New | +$25.8M |
|
273
Denali Therapeutics
DNLI
$3.59B
| $21.1M | 0.03% |
+1,099,719
| New | +$21.9M |
|
274
Novanta
NOVT
$5.22B
| $20.8M | 0.03% |
175,967
+45,348
| +35% | +$5.95M |
|
275
Edgewise Therapeutics
EWTX
$4.27B
| $20.8M | 0.03% |
659,067
-45,010
| -6% | -$1.3M |
|
Similar funds
